Lv64
1820 积分 2023-05-04 加入
Three Versus 6 Months of Adjuvant Oxaliplatin-Fluoropyrimidine Chemotherapy for Colorectal Cancer: Final Results of SCOT—An International, Randomized, Phase III, Noninferiority Trial
5小时前
求助中
Cathepsin-D-mediated MHC class I degradation contributes to immune evasion in colorectal cancer
5小时前
已完结
Risk and Management of Bowel Obstruction in Colorectal Cancer Patients Undergoing Immunotherapy: A Cross-Sectional Multicenter Study
5小时前
已完结
[Analysis on safety and preliminary efficacy of dose-modified regimen of 5-fluorouracil plus oxaliplatin and irinotecan (FOLFOXIRI) in advanced colorectal cancer]
2个月前
已关闭
A Phase I Study of Infusional 5-Fluorouracil, Leucovorin, Oxaliplatin and Irinotecan in Japanese Patients with Advanced Colorectal Cancer Who Harbor <i>UGT1A1</i>*<i>1/</i>*<i>1</i>,*<i>1/</i>*<i>6</i> or *<i>1/</i>*<i>28</i>
2个月前
已关闭
Phase III Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Compared With Infusional Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) As First-Line Treatment for Metastatic Colorectal Cancer: The Gruppo Oncologico Nord Ovest
2个月前
已完结
Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer
2个月前
已完结
Zanzalintinib plus atezolizumab versus regorafenib in refractory colorectal cancer (STELLAR-303): a randomised, open-label, phase 3 trial
2个月前
已完结
RET fusions in solid tumors
3个月前
已完结
FOLFOXIRI reintroduction in metastatic colorectal cancer
4个月前
已完结
皖公网安备34019202002308
